objective To explore the interest in taking PrEP among Western African men who have sex with men (MSM).
Introduction
Pre-exposure prophylaxis (PrEP) is a highly effective method to reduce the risk of HIV acquisition for men who have sex with men (MSM), as demonstrated by randomised clinical trials [1] [2] [3] . In July 2014, WHO recommended PrEP for MSM as part of a comprehensive HIV prevention package [4] . In September 2015, it updated this recommendation, focusing on individuals at substantial risk of acquiring HIV, rather than on specific populations [5] . In July 2017, it issued 11 modules to support the implementation of PrEP in different settings [6] .
Despite these developments, the data about the acceptability of PrEP in MSM in sub-Saharan Africa are scarce, especially in West Africa where no studies have yet been conducted [7] [8] [9] . Implementing PrEP in MSM in West Africa is crucial given their vulnerability to HIV infection and the high risk of transmission to the general population [10] . HIV prevalence is 15-20% in MSM compared with 0.5-3% in the general population [11] [12] [13] . HIV incidence up to 15.9 per 100 person-years has also been reported [14] . Despite their vulnerability and frequent high-risk sexual behaviours (condomless anal sex, transactional sex, multiple sexual partners) [11, 15] , most MSM in West Africa have limited access to tailor-made combination prevention services [16] .
Behavioural studies have assessed the acceptability of PrEP in different countries to identify potential MSM PrEP users and their needs [17, 18] . A meta-analysis involving 14 040 MSM from low-and middle-income countries showed that 64% of participants were willing to use PrEP [19] . Among the 23 studies included in the meta-analysis, only two reported data from sub-Saharan African countries and had limited MSM samples (126 HIV-negative MSM in South Africa [20] and 55 MSM in Kenya [21] ). We explored the interest in taking PrEP in MSM in West Africa with a view to informing the development of future local evidence-based policies.
Methods
The prospective cohort study CohMSM has been ongoing in four West African countries -Mali (Bamako), Côte d'Ivoire (Abidjan), Burkina Faso (Ouagadougou) and Togo (Lom e) -since June 2015. In each country, MSM are recruited and followed up by a community-based organisation providing services for HIV prevention, care and support. MSM are informed about the study by the medical staff when they attend the clinics or outside the clinics by trained peer-educators involved in the routine activities of these clinics. To be eligible, MSM must be aged 18 years or older and report at least one episode of anal intercourse with another man within the 3 months prior to enrolment. Participants provide written consent to participate. The study protocol received approval from the National Ethics Committee of Mali, Burkina Faso, Côte d'Ivoire and Togo.
Participants are offered quarterly follow-up visits, including free clinical examination, screening for HIV, screening and treatment for other sexually transmitted infections (STI), individualised peer-led support, and the provision of condoms and lubricants. Participants diagnosed with HIV are offered immediate initiation of antiretroviral therapy irrespective of their CD4 cell count and clinical stage.
The present analysis was performed using the data of HIV-negative participants. Data were collected by trained research assistants using standardised face-to-face questionnaires. It is important to note that at the time of the present analysis, PrEP was not yet available.
The main outcome was participants' interest in taking PrEP at baseline. Before assessing this, awareness of PrEP was measured using the following question: 'Have you ever heard of PrEP for HIV prevention?' After this question, the research assistants provided a definition of PrEP as 'taking a medicine before having sex to limit the risk of HIV infection'. Participants then indicated whether they were interested or not in taking PrEP by answering the following question: 'Are you interested in taking PrEP? (yes or no)'. Reasons for no interest were collected using an open-ended question. In addition, participants were asked if they had used antiretroviral medicine (acquired from friends or purchased) to prevent HIV infection in the previous 6 months.
A logistic regression model was used to identify factors associated with interest in taking PrEP. Potential explanatory variables considered in this analyses included:
Socio-demographic and socio-economic characteristics. Age; marital status (married/in a relationship vs. single); educational level (secondary school or lower vs. higher than secondary school); importance of religion (very high vs. high, low or very low); employment status (student, employed, unemployed or manual worker); and self-perception of financial situation (comfortable/just making ends meet vs. difficult/very difficult).
MSM identity and sexual behaviours in the previous 6 months. Self-defined sexual identity (bisexual vs. not bisexual); sexual attraction (to men only, to both men and women, more to women than to men); condom use during anal sex (for the main partner and for casual partners) assessed using a 4-point Likert scale dichotomised into inconsistent condom users ('almost always', 'sometimes', 'never') and consistent condom users ('always'); transactional sex (i.e. 'having sex with a man to receive money, accommodation or other material benefit'); number of male sexual partners (<2 vs. ≥2); declaring at least one female sex partner (regular or casual); searching for male sexual partners on the Internet in the previous month; and having sex with HIV-positive partners on antiretroviral therapy (i.e. 'In the last 6 months, have you had sex without condoms with HIV-positive partners only when you knew they were on antiretroviral treatment, and that the risk of HIV infection was therefore reduced?').
Psychosocial characteristics. Experience of stigma in the previous 6 months (assessed using a subscore based on five questions from a validated scale [22] , Cronbach's alpha = 0.66, ranging from 5 to 20); self-esteem (assessed using Rosenberg's scale [23, 24] , Cronbach's alpha = 0.76, ranging from 10 to 20); depression (assessed using Patient Health Questionnaire-9 scale [25, 26] , Cronbach's alpha = 0.82, ranging from 0 to 27); social support from close friends (psychological and material support, only psychological support, no support); and being a member of a local LGBT organisation.
Clinical characteristics. Having at least one STI at enrolment; being diagnosed for syphilis at enrolment.
All explanatory variables associated with interest in taking PrEP with a P-value < 0.25 in the univariate analyses were eligible for the full multivariate model. The final multivariate model was estimated using a backward elimination procedure. Country-specific fixed-effects were taken into account in all the estimations. Analyses were performed using SAS software (version 9.4).
Results
Of the 581 HIV-negative MSM included in the CohMSM study as of 7 June 2017, 564 (97%) participants had complete baseline data and were included in this analysis. Most of these were from Bamako (40%) ( Table 1) . Participants from Abidjan, Ouagadougou and Lom e represented 22%, 19% and 19% of the total sample, respectively. Median age was 24 years (interquartile range, IQR = 21-27), 67% were single, 38% were students and 58% reported financial difficulties. Fifty-four per cent defined themselves as bisexual, while 52% declared they were sexually attracted to men only. With respect to the 6 months before enrolment, more than half the participants reported inconsistent condom use during anal sex (54%), 38% declared transactional sex and 62% reported two or more male sexual partners. 39% had searched for male sexual partners on the Internet in the previous month. Only 7% had had sex with HIV-positive partners on antiretroviral therapy in the previous 6 months. With regard to psychosocial characteristics, participants had a low median score (interquartile range [IQR]) for stigma (5 [5] [6] [7] ), a low score for depression (3 [0-6]) and a high score for self-esteem (18 [16] [17] [18] [19] ). With respect to the previous 6 months, few participants (9%) had received psychological and material support from close friends, and 13% had had at least one STI.
Only 84 participants (15%) were aware of PrEP. Irrespective of PrEP awareness, 488 participants (87% -our reference value) declared interest in taking PrEP. Among the 76 participants not interested, the main reasons were doubt about its effectiveness (33%), preference for condoms (25%) and feeling they did not need it (11%). Only one participant (from Ouagadougou) reported using antiretroviral medicine to prevent HIV acquisition in the 6 months prior to enrolment.
Proportions of participants interested in taking PrEP according to characteristics and the factors associated with univariate and multivariate analyses are described in Table 2 . In Lom e, Bamako, Ouagadougou and Abidjan, respectively, 91%, 89%, 85% and 80% of participants were interested in taking PrEP. High proportions were also observed for participants reporting inconsistent condom use during anal sex in the previous 6 months (90%), for those who had transactional sex in the previous 6 months (92%), for those who searched for sexual partners on the Internet in the previous month (92%) and for those who had at least one STI at enrolment (96%). Conversely, low (with respect to our reference value of 87%) proportions were found for those more sexually attracted to women than to men (64%), and for those who received psychosocial and material support from close friends (73%). In terms of marital status, educational level, socio-economic characteristics, sexual identity, number of sexual partners and membership of an LGBT association, proportions of participants interested in PrEP were approximately 87%.
In univariate analysis, interest in taking PrEP was significantly associated with living in cities (P < 0.02), educational level (P = 0.048), sexual attraction (P = 0.001), inconsistent condom use during anal sex in the previous 6 months (P = 0.011), transactional sex in the previous 6 months (P = 0.005), searching for male sexual partners on the Internet in the previous month (P = 0.004), level of self-esteem (P = 0.013), support from close friends (P < 0.03), presence of at least one STI in the previous 6 months (P = 0.023) and awareness of PrEP (P = 0.009).
After adjustment, we found that participants reporting inconsistent condom use during anal sex in the previous 6 months (adjusted odds ratio (aOR): 2.11; 95% confidence interval (CI) 1.21-3.67) and those declaring transactional sex in the previous 6 months (aOR: 2.08; 95% CI 1.13-3.81) were significantly more interested in taking PrEP than their counterparts. Similarly, participants having at least one STI at enrolment (aOR: 5.18; 95% CI 1.43-18.76) and those searching for male sexual partners on the Internet in the previous month (aOR: 1.90; 95% CI 1.03-3.51) were also more interested. Finally, participants with a high level of self-esteem (aOR: 1.21; 95% CI 1.06-1.38) and those unaware of PrEP (aOR: 2.03; 95% CI 1.04-3.96) were also more interested in taking PrEP. In contrast, participant more sexually attracted to women than to men (vs. MSM attracted only to men, aOR: 0.21; 95% CI 0.07-0.60), those who had sex with HIV-positive partners on antiretroviral therapy in the previous 6 months (aOR: 0.28; 95% CI 0.11-0.74), and those declaring psychological and material support from close friends (vs. MSM having no support) (aOR: 0.31; 95% CI 0.14-0.69) were less interested in taking PrEP. 
Discussion
Our study in West Africa showed that 87% of MSM were interested in taking PrEP. This finding is comparable with previous data in South Africa (75%) and Kenya (83%) [20, 21] . Importantly, MSM most at risk of HIV infection were particularly interested in taking PrEP, specifically, those reporting inconsistent condom use during anal sex, those declaring transactional sex, those searching for sexual partners on the Internet and those reporting recent STI. These results are consistent with previous studies conducted in low-, middle-and highincome countries [18, 19, 27] . It is worth noting that introducing PrEP is likely to have the greatest impact in these subgroups of MSM. Surprisingly, our findings indicated that participants aware of PrEP were less interested in taking it than those unaware of it. One previous multicentre research study reported similar results [28] . Reasons for this discrepancy are unclear and merit investigation. Furthermore, our results indicated that psychosocial factors might also influence interest in taking PrEP. Participants who reported being more sexually attracted to women than to men were significantly less interested in taking PrEP. This contrasts with Karuga et al.'s [21] findings in Kenya. This discrepancy could be explained by a lower risk perception of HIV infection in this small group of MSM, as HIV risk acquisition during vaginal intercourse is lower than during anal sex [29] and this group may have sexual intercourse less often with male sexual partners than MSM only attracted to men. We also showed that participants having a high level of self-esteem were more interested in taking PrEP. This may reflect greater acceptability of their sexual practices and a greater understanding of risk-taking behaviours. Indeed, studies on Hispanic MSM in the United States highlighted that MSM who had a high level of self-esteem were more likely to report high-risk sexual behaviours [30, 31] .
Study limitations should be acknowledged. First, we performed the study on a convenience sample of MSM attending community-based organisations, who might not be representative of the global MSM community in the four study countries. Second, participants' responses may have been limited by social desirability bias, resulting in an overestimation of the interest in taking PrEP and an underestimation of reported high-risk sexual behaviours. Third, only limited data were collected on the interest in taking PrEP, which restricts interpretation of estimations, such as the association between interest in taking PrEP and, for example, awareness of PrEP, or lack of psychological and material support from close friends.
Conclusions
Our findings suggest that HIV-negative MSM in West Africa are very interested in taking PrEP, especially those most at risk of HIV infection. Implementation of PrEP programs as part of a comprehensive prevention package should be considered urgently.
